Boca Simina M, Pfeiffer Ruth M, Sampson Joshua N
Innovation Center for Biomedical Informatics, Georgetown University Medical Center, 2115 Wisconsin Avenue, Suite 110, Washington, DC 20007, USA.
Department of Oncology, Georgetown University Medical Center, 3970 Reservoir Road NW, Research Building, Suite E501, Washington, DC 20057, USA.
Biom J. 2017 May;59(3):496-510. doi: 10.1002/bimj.201600013. Epub 2017 Feb 14.
Meta-analysis can average estimates of multiple parameters, such as a treatment's effect on multiple outcomes, across studies. Univariate meta-analysis (UVMA) considers each parameter individually, while multivariate meta-analysis (MVMA) considers the parameters jointly and accounts for the correlation between their estimates. The performance of MVMA and UVMA has been extensively compared in scenarios with two parameters. Our objective is to compare the performance of MVMA and UVMA as the number of parameters, p, increases. Specifically, we show that (i) for fixed-effect (FE) meta-analysis, the benefit from using MVMA can substantially increase as p increases; (ii) for random effects (RE) meta-analysis, the benefit from MVMA can increase as p increases, but the potential improvement is modest in the presence of high between-study variability and the actual improvement is further reduced by the need to estimate an increasingly large between study covariance matrix; and (iii) when there is little to no between-study variability, the loss of efficiency due to choosing RE MVMA over FE MVMA increases as p increases. We demonstrate these three features through theory, simulation, and a meta-analysis of risk factors for non-Hodgkin lymphoma.
荟萃分析可以对多个参数的估计值进行平均,例如一项治疗对多个结局的影响,这是在各项研究之间进行的。单变量荟萃分析(UVMA)单独考虑每个参数,而多变量荟萃分析(MVMA)则联合考虑这些参数,并考虑它们估计值之间的相关性。MVMA和UVMA的性能已在具有两个参数的情况下进行了广泛比较。我们的目标是随着参数数量p的增加,比较MVMA和UVMA的性能。具体而言,我们表明:(i)对于固定效应(FE)荟萃分析,使用MVMA的益处会随着p的增加而大幅增加;(ii)对于随机效应(RE)荟萃分析,MVMA的益处会随着p的增加而增加,但在研究间变异性较高的情况下,潜在的改善幅度较小,并且由于需要估计越来越大的研究间协方差矩阵,实际的改善进一步降低;(iii)当研究间几乎没有变异性时,由于选择RE MVMA而非FE MVMA导致的效率损失会随着p的增加而增加。我们通过理论、模拟以及对非霍奇金淋巴瘤危险因素的荟萃分析来证明这三个特征。